ArticleFrontiers in oncology2026

FOXI3 promotes migration and proliferation in prostate cancer bone metastases, modulated by FGF8.

Angana Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.